Gilead, Bristol-Myers Say Direct Buyers Antitrust Suit Too Late
By Hannah Albarazi · February 11, 2021, 11:00 PM EST
Gilead Sciences and Bristol-Myers Squibb urged a California federal judge Thursday to nix direct buyers' claims alleging the pharmaceutical companies engaged in anti-competitive conduct to block generic competition and keep HIV...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login